Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 1
2020 4
2021 9
2022 6
2023 3
2024 5
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Precision medicine for acute myeloid leukemia.
Marconi G, Guolo F, Nanni J, Papayannidis C. Marconi G, et al. Among authors: nanni j. Front Oncol. 2023 Jul 25;13:1233757. doi: 10.3389/fonc.2023.1233757. eCollection 2023. Front Oncol. 2023. PMID: 37560469 Free PMC article. No abstract available.
Acute Myeloid Leukemia Mutations: Therapeutic Implications.
Papayannidis C, Sartor C, Marconi G, Fontana MC, Nanni J, Cristiano G, Parisi S, Paolini S, Curti A. Papayannidis C, et al. Among authors: nanni j. Int J Mol Sci. 2019 Jun 3;20(11):2721. doi: 10.3390/ijms20112721. Int J Mol Sci. 2019. PMID: 31163594 Free PMC article. Review.
Consent 2.0: Informed choices in the age of artificial intelligence.
Farid Y, Chang C, Marcasciano M, Di Meglio F, Rodríguez-Mantilla I, Nanni J, Ortiz S, Chen HC. Farid Y, et al. Among authors: nanni j. Surgery. 2024 May;175(5):1454-1455. doi: 10.1016/j.surg.2023.12.027. Epub 2024 Feb 16. Surgery. 2024. PMID: 38368124 No abstract available.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Todisco E, Papayannidis C, Fracchiolla N, Petracci E, Zingaretti C, Vetro C, Martelli MP, Zappasodi P, Di Renzo N, Gallo S, Audisio E, Griguolo D, Cerchione C, Selleri C, Mattei D, Bernardi M, Fumagalli M, Rizzuto G, Facchini L, Basilico CM, Manfra I, Borlenghi E, Cairoli R, Salutari P, Gottardi M, Molteni A, Martini V, Lunghi M, Fianchi L, Cilloni D, Lanza F, Abruzzese E, Cascavilla N, Rivellini F, Ferrara F, Maurillo L, Nanni J, Romano A, Cardinali V, Gigli F, Roncoroni E, Federico V, Marconi G, Volpi R, Sciumè M, Tarella C, Rossi G, Martinelli G; AVALON Cooperative Group. Todisco E, et al. Among authors: nanni j. Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24. Cancer. 2023. PMID: 36692409 Free article.
Impact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.
Marconi G, Petracci E, Lanzarone G, Vetro C, Martelli MP, Papayannidis C, Audisio E, Minetto P, Riva C, Guolo F, Martini G, Zappasodi P, Vincenzo F, Gigli F, Griguolo D, Rondoni M, Ciotti G, Borlenghi E, Ciccone N, Palumbo FE, Nanni J, Mattei D, Bernardi M, Cignetti A, Zingaretti C, Vertogen B, Cerchione C, Lanza F, Cilloni D, Brunetti L, Palmieri R, Curti A, Giannini MB, Todisco E; AVALON research group; Fracchiolla N, Martinelli G. Marconi G, et al. Among authors: nanni j. Am J Hematol. 2025 Apr;100(4):708-711. doi: 10.1002/ajh.27591. Epub 2025 Jan 20. Am J Hematol. 2025. PMID: 39831709 Free PMC article.
Tracking Response and Resistance in Acute Myeloid Leukemia through Single-Cell DNA Sequencing Helps Uncover New Therapeutic Targets.
Bruno S, Borsi E, Patuelli A, Bandini L, Mancini M, Forte D, Nanni J, Barone M, Grassi A, Cristiano G, Venturi C, Robustelli V, Atzeni G, Mosca C, De Santis S, Monaldi C, Poletti A, Terragna C, Curti A, Cavo M, Soverini S, Ottaviani E. Bruno S, et al. Among authors: nanni j. Int J Mol Sci. 2024 Sep 17;25(18):10002. doi: 10.3390/ijms251810002. Int J Mol Sci. 2024. PMID: 39337490 Free PMC article.
Safety Run-In and Part 1 of GIMEMA AML1718: Venetoclax Combined with FLAI as Induction Treatment in Non-Low-Risk AML.
Marconi G, Piciocchi A, Audisio E, Papayannidis C, Cerrano M, Minotti C, Paoloni F, Guolo F, Bocchia M, Rondoni M, Lico A, Carrabba MG, Della Porta MG, Frigeni M, Giaccone L, Beltrami G, Cattaneo C, Di Chio MC, Serio B, Crea E, Freilone R, Capria S, Curti A, Minetto P, la Sala E, Nanni J, Zannetti BA, Simonetti G, Bochicchio MT, Saglio G, Lemoli RM, Venditti A, Vignetti M, Fazi P, Martinelli G. Marconi G, et al. Among authors: nanni j. Blood Adv. 2025 Mar 6:bloodadvances.2024014901. doi: 10.1182/bloodadvances.2024014901. Online ahead of print. Blood Adv. 2025. PMID: 40048742
Upfront intensive treatment analysis of the Italian Cohort Study on FLT3-mutated AML patients (FLAM): The impact of a FLT3 inhibitor addition to standard chemotherapy in the real-life setting.
Nanni J, Azzali I, Papayannidis C, Mulè A, Audisio E, Martelli MP, Scappini B, Chiusolo P, Cambò B, Candoni A, Lunghi M, Albano F, Olivieri A, Fracchiolla N, Bernardi M, Romani C, Rigolin GM, Giannini MB, Bocchia M, Todisco E, Cilloni D, Bochicchio MT, Ottaviani E, Mattei A, Zamagni F, Valli I, Volpi R, Marconi G, Petracci E; FLAM Collaborative Group; Martinelli G. Nanni J, et al. Cancer. 2025 Apr 1;131(7):e35824. doi: 10.1002/cncr.35824. Cancer. 2025. PMID: 40159434 Free PMC article.
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia.
Ragaini S, Wagner S, Marconi G, Parisi S, Sartor C, Nanni J, Cristiano G, Talami A, Olivi M, Ocadlikova D, Ciciarello M, Corradi G, Ottaviani E, Papayannidis C, Paolini S, Vadakekolathu J, Cavo M, Rutella S, Curti A. Ragaini S, et al. Among authors: nanni j. Blood Adv. 2022 Jan 11;6(1):87-99. doi: 10.1182/bloodadvances.2021004878. Blood Adv. 2022. PMID: 34535017 Free PMC article.
30 results